Home・Список акций・MediciNova Inc

MediciNova Inc

Закрыт

СекторЗдравоохранение

1.29 -0.77

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.28

Макс.

1.3

Ключевые показатели
By Trading Economics
Доход	216K -2.6M
Продажи	35K 187K
Прибыль на акцию	-0.05
Рентабельность продаж	-1,383.144
Сотрудники	6
EBITDA	312K -2.5M

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+510.69% upside

Дивиденды
By Acuity
Следующий отчет о доходах	19 авг. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-4.4M 65M
Предыдущая цена открытия	2.06
Предыдущая цена закрытия	1.29

Новостные настроения

By Acuity

50%

163 / 340 Рейтинг в Healthcare

MediciNova Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

13 авг. 2026 г., 19:26 UTC

MediciNova Inc shares are lower amid broader market pressure from rising jobless claims and stabilizing inflation indicators. The stock trades near its one-month range low.

12 авг. 2026 г., 19:56 UTC

MediciNova Inc. shares are trading roughly flat with no specific news identified, remaining near the lower end of their one-month trading range.

11 авг. 2026 г., 20:06 UTC

MediciNova Inc. shares are roughly flat, showing little movement since Monday's close and positioned near the lower end of their one-month trading range.

10 авг. 2026 г., 19:46 UTC

MediciNova Inc shares are lower today, continuing a downward trend since Friday. Broader market sentiment is affected by recent U.S. employment data.

7 авг. 2026 г., 19:46 UTC

MediciNova Inc. shares are higher today, recovering from earlier losses. The stock is trading around the middle of its one-month range.

6 авг. 2026 г., 20:13 UTC

MediciNova Inc shares are higher in after-market trading, reflecting strength since Thursday's close amid rising U.S. Treasury yields and a hawkish Fed outlook.

4 авг. 2026 г., 19:36 UTC

MediciNova Inc. shares are trading roughly flat amid broader market reactions to a decline in U.S. core factory orders and ongoing strength in AI sectors.

3 авг. 2026 г., 20:06 UTC

MediciNova Inc. shares are lower, continuing a decline since Friday's close, despite positive movements in major indices like the S&P 500 and Nasdaq 100.

31 июл. 2026 г., 19:56 UTC

Shares of MediciNova Inc. are lower during Friday's session, following a routine decline after an early high. The stock is below its 20-day moving average.

30 июл. 2026 г., 20:51 UTC

MediciNova Inc's shares are lower in after-market hours, reflecting a broader decline in the Biotechnology sub-sector. The asset is near its one-month trading range low.

29 июл. 2026 г., 20:09 UTC

MediciNova Inc shares are lower today, continuing a decline since Tuesday's close, and remain near their opening low amid broader market trends.

28 июл. 2026 г., 18:46 UTC

MediciNova Inc. shares are trading higher today, remaining above Monday's close despite settling back from earlier gains during the session.

27 июл. 2026 г., 19:06 UTC

MediciNova Inc. shares are lower today, reflecting broader market trends amid a significant decline in crude oil prices following eased geopolitical tensions.

24 июл. 2026 г., 23:02 UTC

MediciNova Inc shares increased in after-hours trading, reflecting strong performance since Friday's close, despite mixed market sentiment and no specific company news.

23 июл. 2026 г., 20:06 UTC

MediciNova Inc. shares are lower today, continuing a six-session decline amid routine volatility and remaining significantly below the 20-day moving average.

21 июл. 2026 г., 19:21 UTC

MediciNova Inc. shares are lower amid no specific news, continuing a trend below the 20-day moving average over the past three sessions.

Сравнение c конкурентами

Изменение цены

MediciNova Inc Прогноз

Целевая цена

By TipRanks

510.69% рост

Прогноз на 12 месяцев

Средняя 8 USD 510.69%

Максимум 10 USD

Минимум 6 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для MediciNova Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

2 ratings

Покупка

Удержание

Продажа

Основано на мнении 2 аналитиков, присваивавших рейтинги акциям MediciNova Inc – Данные за последние 3 месяца.

Настроения

By Acuity

163 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании MediciNova Inc

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. The company's product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic and other diseases, including nonalcoholic fatty liver disease and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. It has license agreements with Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals, Ltd.; and Meiji Seika Kaisha, Ltd. The company was incorporated in 2000 and is headquartered in La Jolla, California.